Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Why Should S&L Hold ~ 30 Million Shares?
30mio shares is not correct, it was only about 8,5mio SHARES S&L owned - more than half a year ago:
 
"...as of February 28, 2007, the stock ownership...(was):

Lincoln Ventures, LLC

 

32,248,173

(7)

 

8.52

%


(7) Includes 23,845,100 shares issuable upon the exercise of warrants. "

And I'm quite sure, we'll see no more S&L ownership in the coming proxy (must be out latest at 28th of September)
...oops, only for stillpoint:
"I'm sure" means that this is my opinion in the same manner as I was sure, we wouldn't see another dividend this year - no proof, but simply connecting the obvious...;-))

GLTA
Share
New Message
Please login to post a reply